115 related articles for article (PubMed ID: 38242268)
1. Histone deacetylase 6 suppression of renal tubular epithelial cell promotes interstitial mineral deposition via alpha-tubulin acetylation.
Li S; Wu W; Yang B; Liu Z; Duan X; Sun X; Liu H; Zhang S; Zhou Y; Wu W
Cell Signal; 2024 Apr; 116():111057. PubMed ID: 38242268
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
[TBL] [Abstract][Full Text] [Related]
3. MiR-22-3p inhibits fibrotic cataract through inactivation of HDAC6 and increase of α-tubulin acetylation.
Wang X; Wang L; Sun Y; Chen B; Xiong L; Chen J; Huang M; Wu J; Tan X; Zheng Y; Huang S; Liu Y
Cell Prolif; 2020 Nov; 53(11):e12911. PubMed ID: 32985730
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 Inhibition Alleviates Ischemia- and Cisplatin-Induced Acute Kidney Injury by Promoting Autophagy.
Shi L; Song Z; Li C; Deng F; Xia Y; Huang J; Wu X; Zhu J
Cells; 2022 Dec; 11(24):. PubMed ID: 36552715
[TBL] [Abstract][Full Text] [Related]
5. Acetylation/deacetylation and microtubule associated proteins influence flagellar axonemal stability and sperm motility.
Chawan V; Yevate S; Gajbhiye R; Kulkarni V; Parte P
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33200789
[TBL] [Abstract][Full Text] [Related]
6. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.
Liu W; Fan LX; Zhou X; Sweeney WE; Avner ED; Li X
PLoS One; 2012; 7(11):e49418. PubMed ID: 23152903
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.
Chidambaram A; Rodriguez D; Khan S; Gower L
Urolithiasis; 2015 Jan; 43 Suppl 1(0 1):77-92. PubMed ID: 25119505
[TBL] [Abstract][Full Text] [Related]
9. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.
Çetin Ö; Sari S; Erdem-Yurter H; Bora G
Drug Dev Res; 2022 Jun; 83(4):993-1002. PubMed ID: 35266183
[TBL] [Abstract][Full Text] [Related]
10. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
[TBL] [Abstract][Full Text] [Related]
11. Ferrostatin‑1 alleviates oxalate‑induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis.
Xie J; Ye Z; Li L; Xia Y; Yuan R; Ruan Y; Zhou X
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35703358
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
13. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.
Zhao Z; Xu H; Gong W
Protein Pept Lett; 2010 May; 17(5):555-8. PubMed ID: 19961433
[TBL] [Abstract][Full Text] [Related]
15. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.
Haggarty SJ; Koeller KM; Wong JC; Grozinger CM; Schreiber SL
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4389-94. PubMed ID: 12677000
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic factors MeCP2 and HDAC6 control α-tubulin acetylation in cardiac fibroblast proliferation and fibrosis.
Tao H; Yang JJ; Shi KH; Li J
Inflamm Res; 2016 May; 65(5):415-26. PubMed ID: 26975406
[TBL] [Abstract][Full Text] [Related]
18. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
19. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
20. Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney.
Duan X; Kong Z; Mai X; Lan Y; Liu Y; Yang Z; Zhao Z; Deng T; Zeng T; Cai C; Li S; Zhong W; Wu W; Zeng G
Redox Biol; 2018 Jun; 16():414-425. PubMed ID: 29653411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
